ImmunoGenesis doses 1st patient in phase 1/2 trial of IMGS-101 in combo with balstilimab & zalifrelimab to treat immune-excluded tumours: Houston Saturday, March 8, 2025, 18:00 Hr ...

7, 2025 — A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new ... Breakthrough in Childhood Brain Cancer ...

A real-world study showed HER2DX guided treatment changes in approximately 48% of HER2-positive breast cancer cases.

Mar. 12, 2025 — Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive ...

1Houston Methodist Neal Cancer Center, Houston, TX.

Poland: A recent simulation study published in Scientific Reports revealed that individuals with asthma and chronic ...

While the HPV vaccine will not cure a preexisting HPV infection, it is the best way to build immunity against future HPV infections and prevent cervical cancer. Fortunately, 80% to 90% of HPV ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

Tumour immunology describes the interaction between cells of the immune system with tumour cells. Understanding these interactions is important for the development of new therapies for cancer ...